Great Valley Advisor Group Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 593.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,273 shares of the medical equipment provider's stock after acquiring an additional 4,513 shares during the quarter. Great Valley Advisor Group Inc.'s holdings in Intuitive Surgical were worth $1,058,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 28,519,307 shares of the medical equipment provider's stock worth $8,603,704,000 after acquiring an additional 457,262 shares during the period. BlackRock Inc. increased its position in shares of Intuitive Surgical by 0.5% during the first quarter. BlackRock Inc. now owns 26,660,811 shares of the medical equipment provider's stock worth $8,043,033,000 after acquiring an additional 122,151 shares during the period. State Street Corp increased its position in shares of Intuitive Surgical by 2.3% during the first quarter. State Street Corp now owns 15,182,214 shares of the medical equipment provider's stock worth $4,580,170,000 after acquiring an additional 347,468 shares during the period. Capital World Investors increased its holdings in Intuitive Surgical by 0.3% during the first quarter. Capital World Investors now owns 9,687,380 shares of the medical equipment provider's stock valued at $2,922,569,000 after buying an additional 28,839 shares during the period. Finally, Edgewood Management LLC increased its holdings in Intuitive Surgical by 20.3% during the first quarter. Edgewood Management LLC now owns 8,902,682 shares of the medical equipment provider's stock valued at $2,685,761,000 after buying an additional 1,504,353 shares during the period. 82.44% of the stock is owned by hedge funds and other institutional investors.
Get
Intuitive Surgical alerts:
Intuitive Surgical Stock Performance
ISRG opened at $192.40 on Thursday. Intuitive Surgical, Inc. has a fifty-two week low of $184.94 and a fifty-two week high of $369.69. The company has a fifty day moving average of $217.44 and a two-hundred day moving average of $231.36. The stock has a market capitalization of $68.71 billion, a price-to-earnings ratio of 48.96, a PEG ratio of 5.36 and a beta of 1.31.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a return on equity of 12.04% and a net
margin of 24.05%. The company had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the firm earned $1.42 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current year.
Insider Buying and Selling at Intuitive Surgical
In other news, Director Amal M. Johnson sold 6,375 shares of the company's stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, CEO Gary S. Guthart sold 79,412 shares of the stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the completion of the sale, the chief executive officer now owns 54,607 shares in the company, valued at approximately $11,811,494.10. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 6,375 shares of the firm's stock in a transaction on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now owns 11,224 shares of the company's stock, valued at approximately $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold 101,162 shares of company stock worth $22,062,916 in the last ninety days. 0.90% of the stock is owned by insiders.
Analysts Set New Price Targets
Several equities analysts recently issued reports on the stock. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a report on Friday, September 9th. Morgan Stanley cut their price objective on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a report on Friday, July 15th. Raymond James cut their price objective on shares of Intuitive Surgical from $294.00 to $255.00 in a report on Friday, July 22nd. The Goldman Sachs Group cut their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating on the stock in a report on Friday, July 29th. Finally, Wells Fargo & Company cut their price objective on shares of Intuitive Surgical to $265.00 in a report on Friday, July 22nd. Six equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $268.00.
Intuitive Surgical Profile
(Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- A Trio of Q3 Winners With Room to Run
- This Little Known Small Cap Is Up 139%: Is The Stock A Buy?
- Can HCA Healthcare Weather the Normalization?
- Can United Natural Foods Fight Both Inflation and the Fed?
- Mullen Automotive Is Ready To Get In Gear
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
